W-Z BIOTECH LLC

Lexington, KY · Medtech · Private

Compliant diaphragm displacement pump (cDDP) for pediatric ventricular assist device

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
Lexington, KY
Total capital
$9.9M
Federal grants
$9.9M
16 awards · 2016–2025
Rank in peer group#270 of 538
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
3 pending

Capital timeline

20162018202020222024FEDERAL ↑EQUITY ↓Cumulative $9.9M$1M$715K$1.5M$782K$1.3M$1.6M
20162018202020222024FEDERAL ↑EQUITY ↓Cumulative $9.9M$1M$1.5M$1.3M$1.6M

Latest events

  • Federal grantHealth and Human S · Phase II · Development of a Minimally Invasive Single Cannulation, Compact Single Port Pulsatile Ventricular Assist Device (sppVAD) for Total LV Support$1.6M
  • Federal grantHealth and Human S · Phase II · Development of a Minimally Invasive Single Cannulation, Compact Single Port Pulsatile Ventricular Assist Device (sppVAD) for Total LV Support$1.3M
  • Federal grantHealth and Human S · Phase I · Integration of Compliance Chambers into Diaphragm Displacement Pump to Double the Pumping Flow of Pediatric Paracorporeal Pulsatile Ventricular Assist Device$296K
  • Federal grantHealth and Human S · Phase I · Integration of Compliance Chambers into Diaphragm Displacement Pump to Double the Pumping Flow of Pediatric Paracorporeal Pulsatile Ventricular Assist Device$296K
  • Federal grantHealth and Human S · Phase I · Pediatric Transapical Double Lumen Cannula with Integrated Compliance Chambers Doubles Flow of Paracorporeal Pulsatile VAD$275K
  • Federal grantHealth and Human S · Phase I · Pediatric Transapical Double Lumen Cannula with Integrated Compliance Chambers Doubles Flow of Paracorporeal Pulsatile VAD$275K
  • Federal grantHealth and Human S · Phase I · Development of a Minimally Invasive Single Cannulation, Compact Single Port Pulsatile Ventricular Assist Device (sppVAD) for Total LV Support$225K
Show 9 earlier federal awards
  • Federal grantHealth and Human S · Phase I · Development of a Minimally Invasive Single Cannulation, Compact Single Port Pulsatile Ventricular Assist Device (sppVAD) for Total LV Support$225K
  • Federal grantHealth and Human S · Phase II · Development of a TransApical to Aorta Double Lumen Cannula for a Neonate LVAD$782K
  • Federal grantHealth and Human S · Phase II · Development of a TransApical to Aorta Double Lumen Cannula for a Neonate LVAD$1.5M
  • Federal grantHealth and Human S · Phase II · Development of a TransApical to Aorta Double Lumen Cannula for a Neonate LVAD$715K
  • Federal grantHealth and Human S · Phase I · Development of a Percutaneous Pulmonary Artery Drainage Device to Unload LV During VA ECMO Support for Severe Cardiogenic Shock$225K
  • Federal grantHealth and Human S · Phase I · Development of a Percutaneous Pulmonary Artery Drainage Device to Unload LV During VA ECMO Support for Severe Cardiogenic Shock$225K
  • Federal grantHealth and Human S · Phase II · Development of Percutaneous DLC for Total Cavo-pulmonary Assistance$543K
  • Federal grantHealth and Human S · Phase II · Development of Percutaneous DLC for Total Cavo pulmonary Assistance$1M
  • Federal grantHealth and Human S · Phase II · Development of Percutaneous DLC for Total Cavo-pulmonary Assistance$458K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 3
  • PendingPercutaneous Pulmonary Artery Drainage DeviceUSPTOApplication 17232594
  • PendingDual Lumen Cannula For Artificial Lung And Right Ventricular Assist DeviceUSPTOApplication 14635105
  • PendingPercutaneous Dual-lumen Cannula For Cavopulmonary Assist DeviceUSPTOApplication 13836880
  • ARBORSENSE INCSimilar federal contract value in Medtech · null in contracts
  • O2M Technologies, LLCSimilar federal contract value in Medtech · null in contracts
  • MICROVASCULAR TISSUES, INC.Similar federal contract value in Medtech · null in contracts
  • CadnzaMed LLCSimilar federal contract value in Medtech · null in contracts
  • Naturemiri, LLCSimilar federal contract value in Medtech · null in contracts
  • VIBO HEALTH INCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .